QbD – Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance

17. August 2014

Related Articles

Advances in Nanocarrier Systems for Overcoming Formulation Challenges of Curcumin: Current Insights

Beyond Tableting Lubrication – PRUV® by JRS Pharma

Polymeric microspheres redefining the landscape of colon-targeted delivery: A contemporary update

QbD – Understanding How Excipient Properties Influence Solid Oral Dosage Form Performance

Dr Amina Faham (Dow), Dr Liz Meehan (AstraZeneca)

at ExcipientFest, Amsterdam NL – June 24, 2014